Inavir Pharmatech Private Limited - Due diligence report

A 360° intelligence report on Inavir Pharmatech Private Limited: trust score, financial health, credit view, compliance, directors, growth a…

2011-07-28 Hyderabad, Telangana Active Unlisted Active Compliant
Share
IP Inavir Pharmatech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Inavir Pharmatech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Inavir Pharmatech Private Limited is assessed as Low Risk with a Trust Score of 86/100. Inavir Pharmatech Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Chemicals and Materials sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Inavir Pharmatech Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Profitable - internal accruals available.

Charges position: 1 open (74.87 Lakh) · 2 satisfied (8.65 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUJATHA TANNIRU 01234567 Director 01/04/2018 6 yrs Approved
VIJAY BHASKAR BANDLA 01234567 Director 01/04/2018 6 yrs Approved
KRUTIKA MISRA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
10 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: VIJAY BHASKAR BANDLA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 75
Growth signals & trust indicators
Net margin improved to 1.42.
Operating for 14+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 74.87 Lakh already registered.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
12 Mar 2025
Charge satisfied
Others
19 Apr 2022
Charge created
Others - 74.87 Lakh
20 Jul 2019
Charge created
Others - 8.15 cr
18 Dec 2017
Charge satisfied
Others
25 Jan 2017
Securities allotted
100000 Equity Shares Without Differential Rights - 10.00 Lakh raised
16 Jan 2017
Securities allotted
100000 Equity Shares Without Differential Rights - 10.00 Lakh raised
29 Mar 2016
Charge created
Others - 50.00 Lakh
08 Oct 2015
Director ceased
JAGADESHWAR RAO MADHAVARAM
22 Jul 2015
Director appointed
SUJATHA TANNIRU (Additional Director)
02 Jun 2015
Securities allotted
80000 Equity Shares Without Differential Rights - 8.00 Lakh raised
30 May 2015
Securities allotted
80000 Equity Shares Without Differential Rights - 8.00 Lakh raised
26 May 2015
Securities allotted
200000 Equity Shares Without Differential Rights - 20.00 Lakh raised
11 Nov 2014
Securities allotted
200000 Equity Shares Without Differential Rights - 20.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 10 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Daoming Reflective Material India Private Limited U29308HR2017FTC070787 Gurgaon, Haryana, India
Gopaldas Hiranand Private Limited U52110MP2019PTC048258 Rewa, Madhya Pradesh, India
Om Biogenics Private Limited U51909WB2009PTC139932 Kolkata, West Bengal, India
Pawan Pulses Private Limited U15495WB2009PTC139855 Kolkata, West Bengal, India
Globeam Radiant Private Limited U31900DL2017PTC320880 New Delhi, Delhi, India
Klingspor India Private Limited U51909PN2012FTC143496 Pune, Maharashtra, India
Amo Tradelink Private Limited U51900GJ2011PTC064796 Ahmedabad, Gujarat, India
K R Traders Pvt Ltd U51909AS1987PTC002815 Guwahati, Assam, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Inavir Pharmatech Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Inavir Pharmatech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 45/100, margin trends, ownership structure and peer set for Inavir Pharmatech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Inavir Pharmatech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Inavir Pharmatech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Inavir Pharmatech Private Limited an active company?

Inavir Pharmatech Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Inavir Pharmatech Private Limited financially healthy?

Inavir Pharmatech Private Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Inavir Pharmatech Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Inavir Pharmatech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Inavir Pharmatech Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Inavir Pharmatech Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Inavir Pharmatech Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.